SEC Form 4 · accession 0001179110-15-014153
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ravindra Kumar
Officer — VP & Chief Scientific Officer
Period of report
Oct 19, 2015
Accepted (ET)
Oct 21, 2015 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 19, 2015 | M | 2,300 | $1.80 | A | 58,985 | D | |
| Common Stock | Oct 19, 2015 | M | 6,250 | $5.08 | A | 65,235 | D | |
| Common Stock | Oct 19, 2015 | M | 5,516 | $5.28 | A | 70,751 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $1.80 | Oct 19, 2015 | M | 2,300 | D | — | Jun 12, 2017 | Common Stock | 2,300 | 0 | D |
| Option to Purchase Common StockF1 | $5.08 | Oct 19, 2015 | M | 6,250 | D | — | Mar 27, 2018 | Common Stock | 6,250 | 0 | D |
| Option to Purchase Common StockF1 | $5.28 | Oct 19, 2015 | M | 5,516 | D | — | Dec 16, 2021 | Common Stock | 5,516 | 10,984 | D |
Explanation of responses
- F1The options of registrant's common stock vest in equal quarterly installments over the first four years after the grant.